Insights

The role of a Regulatory Coordinator in clinical research is essential for ensuring compliance with applicable regulations and guidelines. This position acts as a pivotal link between clinical trial sites, institutional review boards (IRBs)/ethics committees (ECs), sponsors, and regulatory authorities. Understanding the multifaceted responsibilities and necessary competencies is crucial for individuals pursuing this career path

Clinical trials, the bedrock of medical innovation, are inherently complex. They involve a multifaceted interplay of regulatory compliance, data management, patient recruitment, and logistical coordination. Traditional methods, often reliant on disparate systems and manual processes, can hinder efficiency and introduce opportunities for error. Velos CTMS (Clinical Trial Management System) offers a comprehensive solution designed to

Velos Clinical Trial Management System (CTMS) is a software solution designed to centralize and manage various aspects of clinical trials. It integrates data and processes across the research lifecycle, from study planning and site activation to patient enrollment, data collection, and financial management. By providing a unified platform, Velos CTMS aims to enhance operational efficiency,

Overview of Clinical Trials Clinical trials are research studies performed in people that evaluate a medical, surgical, or behavioral intervention. They are the primary way that researchers determine if a new treatment, such as a new drug, diet, or medical device, is safe and effective in humans. Participation in a clinical trial can offer individuals

This article examines three innovative designs intended to improve the process of dose escalation in clinical trials. These designs represent advancements in methodology, aiming for increased efficiency, safety, and statistical robustness compared to traditional approaches. Before delving into contemporary methods, it is crucial to understand the principles of traditional dose escalation. Historically, the 3+3 design

Navigating the landscape of COVID-19 clinical trials can be a daunting prospect. As the world grappled with an unprecedented pandemic, the scientific community mobilized rapidly, initiating numerous research studies to understand the virus, develop treatments, and create vaccines. For individuals considering participation, understanding the structure, risks, and benefits of these trials is crucial. This article

Clinical trials are research studies performed in people that evaluate a medical, surgical, or behavioral intervention. They are the primary way that researchers determine if a new treatment, such as a new drug, diet, or medical device, is safe and effective in humans. These studies are essential for advancing medical knowledge and improving human health.

Synexus Clinical Research Ltd., commonly referred to as Synexus, is a prominent global site network dedicated to conducting clinical trials. Established in 1992, the company specializes in Phases II, III, and IV pharmaceutical research across various therapeutic areas. Its operations span multiple continents, making it a significant contributor to the advancement of medical science through

The National Institutes of Health (NIH) is a primary agency of the United States government responsible for biomedical and public health research. Its clinical research arm plays a pivotal role in translating scientific discoveries from the laboratory bench to the patient bedside, a process often referred to as translational medicine. This article will explore the

Lightship Clinical Trials is a company specializing in decentralized clinical trials (DCTs). Founded with the aim of modernizing the traditional clinical trial model, Lightship integrates technology and a patient-centric approach to conduct research. The company’s methodology seeks to overcome geographical barriers and enhance patient participation by bringing trial activities directly to participants, often within their